Thank you for the deep dive here longfellow95. I appreciate all the detail and links. I was aware of some of this a long time ago, but dropped off because I knew the shorts were, in fact, targeting the company. The biggest announcement of major short interest is ALWAYS articles by you know who...
I don't even have to say who, because you already know...
When You Know Who (YNW) is writing about (attacking) a random, tiny company, it is virtually ALWAYS the target of a short attack. What would be the fun of writing an article about a company that no one cared about, I suppose? Except these are all tiny, obscure companies that YKW writes about.
That Martin Shkreli crowd was always interesting by the way, but he's just one little teeny, tiny node on a much, much larger tree. An entire industry that squeezes billions out of the markets, by hook or by crook, to appease the backers that put their money into their funds and to pay themselves their 20%, whether they do well or badly, every year. Gotta keep the money spiggot flowing!
As for the "total embargo" by media on NWBO. Don't think this is unique to NWBO. I've been in companies in exactly the same spot before. Most mainstream news organizations will absolutely NOT write about the leading company in an industry, and I saw it with my own eyes in other companies, if it's an OTC penny stock. They will not do it. They have rules against it. They don't want to be caught up in and accused of being a part of a scheme to promote such stocks... and so you can see how the shorts work. They squeeze many of these companies into a corner so dark, that they hope that they cannot get out and that no one can hear the screams of their executives, their shareholders or even the patients helped by their technologies. Even if they could cure blindness or cancer, it doesn't matter. They will treat them the same. That's the reality of being down here. It's why, despite all the reasons that some complain, sometimes you just have to do what you have to do eventually, if it all takes longer than expected, which it virtually always does.
The broad brush discrimination by media cos against OTC penny stocks, is very unfair. They know it's unfair, and they likely won't break that rule for anything. It's broad brush discrimination, for the same reason that we all know a short can make a success into a failure... broad brush attacks work. Once a company is at least on a main exchange, and not in the penny range, then they might even write something positive about them. Oh, one thing, don't think that being an OTC penny stock keeps anyone from writing bad things about such companies. They just want to avoid broad brush attacks that their paper or a journalist PROMOTED such a company, ever. Attacks are a different matter.
However, get a major medical journal article, because they don't care who owns the medical breakthrough or what their balance sheet looks like, most of the time, and you get sudden coverage by mainstream media. I promise you most or many, even if they possibly mention the company's name, they won't publish the ticker. Again, I've been here before, seen it before, and know what happens. But, hopefully NWBO will also bounce from these lows, and be able to qualify for a relisting without anything other than fantastic news, assuming there is fantastic trial news. That's the way it should be, if markets work properly. One thing I've learned is, you can't expect markets to work properly. They do or they don't, but it's not always certain that they will work properly. We see it with all kinds of investment case studies, all the time. But each one is pawned off as unique. Meanwhile, many, many other cases, much more subtle, are barely noticed. Markets working properly is far more of an aspirational expectation than an absolute reality.
But let's hope for medical journal and scientific validation of the Phase III results, to mainstream news, to recognition and hopefully very substantial financial appreciation, on the way to regulatory approval and partnerships that lead the way to greater and greater understanding and methods for eliminating cancer, in its many forms.
News 
Market Data 
Discover 
AI
